SHATTUCK LABS INC (STTK) Fundamental Analysis & Valuation
NASDAQ:STTK • US82024L1035
Current stock price
6.22 USD
+0.12 (+1.97%)
At close:
6.29 USD
+0.07 (+1.13%)
After Hours:
This STTK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. STTK Profitability Analysis
1.1 Basic Checks
- STTK had negative earnings in the past year.
- STTK had a negative operating cash flow in the past year.
- STTK had negative earnings in each of the past 5 years.
- STTK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- STTK's Return On Assets of -53.62% is in line compared to the rest of the industry. STTK outperforms 45.86% of its industry peers.
- STTK has a Return On Equity of -59.24%. This is comparable to the rest of the industry: STTK outperforms 58.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.62% | ||
| ROE | -59.24% | ||
| ROIC | N/A |
ROA(3y)-63.72%
ROA(5y)-51.17%
ROE(3y)-71.42%
ROE(5y)-57.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- STTK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. STTK Health Analysis
2.1 Basic Checks
- STTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for STTK has been increased compared to 1 year ago.
- Compared to 5 years ago, STTK has more shares outstanding
- There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- STTK has an Altman-Z score of 23.44. This indicates that STTK is financially healthy and has little risk of bankruptcy at the moment.
- STTK has a Altman-Z score of 23.44. This is amongst the best in the industry. STTK outperforms 90.75% of its industry peers.
- There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 23.44 |
ROIC/WACCN/A
WACC9.28%
2.3 Liquidity
- A Current Ratio of 11.70 indicates that STTK has no problem at all paying its short term obligations.
- STTK has a Current ratio of 11.70. This is amongst the best in the industry. STTK outperforms 84.59% of its industry peers.
- STTK has a Quick Ratio of 11.70. This indicates that STTK is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of STTK (11.70) is better than 84.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.7 | ||
| Quick Ratio | 11.7 |
3. STTK Growth Analysis
3.1 Past
- STTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.32%, which is quite impressive.
- Looking at the last year, STTK shows a very negative growth in Revenue. The Revenue has decreased by -82.52% in the last year.
- STTK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.82% yearly.
EPS 1Y (TTM)48.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.57%
Revenue 1Y (TTM)-82.52%
Revenue growth 3Y15.44%
Revenue growth 5Y-36.82%
Sales Q2Q%N/A
3.2 Future
- STTK is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.42% yearly.
- Based on estimates for the next years, STTK will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y31.21%
EPS Next 2Y18.13%
EPS Next 3Y7.58%
EPS Next 5Y-1.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. STTK Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for STTK. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STTK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.13%
EPS Next 3Y7.58%
5. STTK Dividend Analysis
5.1 Amount
- No dividends for STTK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
STTK Fundamentals: All Metrics, Ratios and Statistics
6.22
+0.12 (+1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-05 2026-03-05/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners63.81%
Inst Owner Change14.86%
Ins Owners1.65%
Ins Owner Change0%
Market Cap445.10M
Revenue(TTM)1.00M
Net Income(TTM)-48.81M
Analysts80
Price Target7.4 (18.97%)
Short Float %3.22%
Short Ratio2.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.8%
Min EPS beat(2)7.68%
Max EPS beat(2)13.92%
EPS beat(4)4
Avg EPS beat(4)7.86%
Min EPS beat(4)3.96%
Max EPS beat(4)13.92%
EPS beat(8)7
Avg EPS beat(8)7.44%
EPS beat(12)10
Avg EPS beat(12)7.91%
EPS beat(16)12
Avg EPS beat(16)5.97%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)81.25%
EPS NQ rev (1m)-6.42%
EPS NQ rev (3m)-6.42%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 445.1 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.4 | ||
| P/tB | 5.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0.01
BVpS1.15
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.62% | ||
| ROE | -59.24% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-63.72%
ROA(5y)-51.17%
ROE(3y)-71.42%
ROE(5y)-57.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.93% | ||
| Cap/Sales | 7.1% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 11.7 | ||
| Quick Ratio | 11.7 | ||
| Altman-Z | 23.44 |
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)4.51%
Cap/Depr(5y)193.27%
Cap/Sales(3y)10.9%
Cap/Sales(5y)369.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.57%
EPS Next Y31.21%
EPS Next 2Y18.13%
EPS Next 3Y7.58%
EPS Next 5Y-1.42%
Revenue 1Y (TTM)-82.52%
Revenue growth 3Y15.44%
Revenue growth 5Y-36.82%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y36.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.4%
EBIT Next 3Y-24.92%
EBIT Next 5YN/A
FCF growth 1Y34.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.1%
OCF growth 3YN/A
OCF growth 5YN/A
SHATTUCK LABS INC / STTK Fundamental Analysis FAQ
What is the fundamental rating for STTK stock?
ChartMill assigns a fundamental rating of 3 / 10 to STTK.
Can you provide the valuation status for SHATTUCK LABS INC?
ChartMill assigns a valuation rating of 0 / 10 to SHATTUCK LABS INC (STTK). This can be considered as Overvalued.
Can you provide the profitability details for SHATTUCK LABS INC?
SHATTUCK LABS INC (STTK) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for STTK stock?
The Earnings per Share (EPS) of SHATTUCK LABS INC (STTK) is expected to grow by 31.21% in the next year.